Sanjay Shukla - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Sanjay Shukla. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Sanjay Shukla has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Sanjay Shukla. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ATYR / aTyr Pharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATYR / aTyr Pharma, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2024-05-31	LIFE	Shukla Sanjay	20,000	1.8070	20,000	1.8070	36,140	4	1.9000	1,860	5.15
2023-12-12	LIFE	Shukla Sanjay	12,000	1.1780	12,000	1.1780	14,136
2023-12-11	LIFE	Shukla Sanjay	3,000	1.1700	3,000	1.1700	3,510
2023-11-13	LIFE	Shukla Sanjay	13,578	1.1110	13,578	1.1110	15,085
2023-11-10	LIFE	Shukla Sanjay	1,422	1.1380	1,422	1.1380	1,618
2023-07-28	LIFE	Shukla Sanjay	15,000	2.0149	15,000	2.0149	30,224
2022-11-21	LIFE	Shukla Sanjay	10,000	2.1405	10,000	2.1405	21,405
2022-07-01	LIFE	Shukla Sanjay	15,000	2.8776	15,000	2.8776	43,164
2022-01-07	LIFE	Shukla Sanjay	5,000	6.7613	5,000	6.7613	33,806
2021-11-15	LIFE	Shukla Sanjay	2,500	8.5750	2,500	8.5750	21,438
2021-05-18	LIFE	Shukla Sanjay	10,000	4.0100	10,000	4.0100	40,100
2020-06-19	LIFE	Shukla Sanjay	6,000	4.2700	6,000	4.2700	25,620

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales ATYR / aTyr Pharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATYR / aTyr Pharma, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2021-02-09	LIFE	Shukla Sanjay	778	7.6600	778	7.6600	5,959	93	3.62	-3,143	-52.74
2020-02-07	LIFE	Shukla Sanjay	745	4.0300	745	4.0300	3,002

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Sanjay Shukla as disclosed to the Securities Exchange Commission (SEC).